Hims even bought a 503B outsourcing facility in California this fall in order to continue to deliver on sterile compounded products like GLP-1 injections. But in the event the FDA lifts the shortage designation, Hims appears to be counting on the narrower 503A process to justify its investments in compounding
Efforts should be taken to overcome these challenges in order to address AMR, as the combination of antibiotics and the antibiotic potentiator molecule can significantly contribute to combating AMR
Moisture escapes
received honoraria for speaking at meetings from Novartis, Sanofi, Lilly, Astrazeneca, and NovoNordisk
These therapies can promote a variety of health benefits, such as enhancing muscle growth, supporting weight management, improving skin health, reducing inflammation, and optimizing hormone balance